Celebrating 20 Years of Training in Botox®, Aesthetic Medicine
and Medical Weight Management

Start Training Now
IAPAM Logo
Aesthetic Medicine Symposium - September 18-21 in Scottsdale, AZ! Secure Your Spot

Celebrating 20 Years of Excellence in Botox®, Aesthetic Medicine & Medical Weight Management Training & Certification

IAPAM Logo
Aesthetic Medicine Symposium — Sept 18–21, Scottsdale, AZ   Secure Your Spot →
Home » Medical Weight Management Library  » Ozempic® Wegovy® Blindness – Truth or Myth?

Ozempic® Wegovy® Blindness - Truth or Myth?

Recent findings have raised concerns about a possible connection between certain diabetes and weight-loss medications, specifically Ozempic® and Zepbound®, and rare eye conditions that could lead to vision loss. These results were published in the scientific journal JAMA Ophthalmology.

Ozempic Wegovy Blindness

Ozempic® Overview

Ozempic® functions by replicating the effects of the GLP-1 hormone. This hormone plays a crucial role in boosting insulin production, lowering glucagon levels, slowing down the emptying of the stomach, and curbing appetite. These combined effects assist in managing blood sugar levels for individuals with type 2 diabetes and promote weight loss for those who are overweight or obese.

What the Study Found

The study looked at nine patients who were taking drugs containing semaglutide, the active ingredient found in Ozempic® and Wegovy®, or tirzepatide, found in Mounjaro and Zepbound®. Here’s what was discovered:

– Seven of the nine patients developed a rare eye condition called NAION, which affects blood flow to the optic nerve and can cause sudden and permanent blindness. NAION is the most common optic nerve disease in older adults in the United States.
– One patient experienced bilateral papillitis, which means swelling of both optic nerve heads.
– Another patient developed a condition called paracentral acute middle maculopathy, which involves the loss of blood flow to a part of the retina.

Reserve Your Spot
AN IAPAM TRAINING | September 18-21, 2026 | Limited Time Offer: Save 15% on registration
Gain the confidence you need — build the lifestyle & practice you deserve

Includes hands-on Botox® injection training on live models in a clean clinic setting

33.5 CMES | 4-Day Hands-On | Scottsdale, Arizona | Save up to $3,605
AN IAPAM TRAINING | September 18-21 | Save 15% on Registration
Gain the confidence you need — build the lifestyle and practice you deserve
33.5 CMEs | 4-Day Hands-On | Scottsdale, Arizona | Save up to $3,605
Reserve Your Spot

Why Might This Be Happening?

The researchers believe that these eye problems might be linked to rapid changes in blood sugar levels caused by these drugs, rather than the drugs themselves directly damaging the eyes.

What the Companies Say

Novo Nordisk, the maker of Ozempic®, stressed that patient safety is very important to them. They have looked into reports of eye conditions among users of their medications and found no direct evidence that the drugs cause NAION. They noted that eye issues are common in people with diabetes, regardless of the medication they take.

The lead researcher, Dr. Bradley Katz, emphasized that the study is not advising people to stop taking these medications. Instead, if you notice any changes in your vision while on these drugs, you should talk to your doctor and see an eye specialist promptly.

Looking at the Bigger Picture

Earlier studies from last year also suggested a possible connection between semaglutide and NAION. One such study found that diabetes patients using Ozempic® were more than twice as likely to develop NAION compared to those using other diabetes drugs. However, it’s important to note that the overall risk remains low. According to the study, for someone taking Ozempic® for 20 years, the chance of developing NAION is estimated to be between 0.3% and 0.5%.

The company explained that NAION, a serious eye condition, is not listed as a known side effect for their drugs like Ozempic® and Wegovy®. After looking at this new study, they believe that the overall benefits and risks of semaglutide, the active ingredient in these medications, are still the same as before.

What This Means for You

If you’re taking Ozempic®, Zepbound®, or similar medications, there is currently no strong evidence that these drugs directly harm your eyes. However, it’s crucial to monitor any changes in your vision and report them to your healthcare provider. Regular check-ups with your eye doctor can also help catch any problems early, ensuring your eye health is protected while managing your diabetes.

IAPAM Learning Lab

Your next clinical skill should not have to wait for your next free weekend.

Patients are already asking about GLP-1s, injectables, PRP, lasers, and aesthetic treatments. Build the knowledge to have better clinical conversations now—on a schedule that works around your practice.

✓Start with the clinical topic your patients are asking about today.
✓Learn at your pace, then revisit the material as you integrate new services.
✓Explore focused training in medical weight management and aesthetic medicine.
Explore On-Demand Training →

Need hands-on BOTOX® training instead? Explore IAPAM’s Botox training options →

Disclaimer: The information provided here is for general knowledge only and should not be considered medical advice. For any questions or concerns about your health or medications, please consult your physician or healthcare provider. They are best equipped to provide guidance specific to your medical needs.

Medical Weight Management Training

Ready to Build a GLP-1 Weight Management Program?

Build the clinical, operational, and business foundations to evaluate GLP-1 weight-management services for your practice—without handing your patient relationships to a corporate intermediary.

Explore GLP-1 Certification Training →
✓Build direct patient relationshipsLearn a practice-centered approach to GLP-1 weight management and patient education.
✓Create a stronger program foundationExplore patient flow, clinical considerations, and practical service-development decisions.
✓Stay informed as the field evolvesBuild context for evidence, protocol, and regulatory considerations that affect medical weight management.
✓Bring business and clinical learning togetherLearn practice-building fundamentals alongside the clinical foundations for responsible growth.

Want to add Botox® training to your broader practice plan? Explore IAPAM’s Botox training options →

Ready to Transform Your Practice with GLP-1s?

Request your Quick Start Checklist for Starting or Integrating a New GLP-1 for Weight Loss Guide.

Request your free copy